BEONE MEDICINES LTD. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
BEONE MEDICINES LTD. (BEIGF) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $43.54 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-10
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $43.54M, a 7.93% increase year-over-year.
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$170.72M, a 2437.98% decline year-over-year.
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $44.08M, a 604.76% increase year-over-year.
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$135.55M.
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$221.85M.
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$58.91M.
- BEONE MEDICINES LTD. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$33.64M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $43.54M 10-Q · filed 2017-05-10 | -$127.18M derived: sum of 2 quarters · filed 2017-05-10 | -$83.10M derived: sum of 3 quarters · filed 2017-05-10 | -$218.65M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -$170.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$126.64M derived: sum of 2 quarters · filed 2017-03-22 | -$262.19M derived: sum of 3 quarters · filed 2017-03-22 | -$221.85M 10-K · filed 2017-03-22 |
| 2016-09-30 | $44.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$91.47M derived: sum of 2 quarters · filed 2016-11-10 | -$51.13M 10-Q · filed 2016-11-10 | -$43.83M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-06-30 | -$135.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$95.20M 10-Q · filed 2016-08-10 | -$87.90M derived: sum of 3 quarters · filed 2017-05-10 | -$81.65M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-03-31 | $40.34M 10-Q · filed 2017-05-10 | $47.65M derived: sum of 2 quarters · filed 2017-05-10 | $53.90M derived: sum of 3 quarters · filed 2017-05-10 | -$21.79M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $13.56M derived: sum of 2 quarters · filed 2017-03-22 | -$62.14M derived: sum of 3 quarters · filed 2017-03-22 | -$58.91M 10-K · filed 2017-03-22 |
| 2015-09-30 | $6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$69.44M derived: sum of 2 quarters · filed 2016-11-10 | -$66.21M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | -$75.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$72.46M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | $3.23M 10-Q · filed 2016-05-12 | |||
| 2014-12-31 | -$33.64M 10-K · filed 2017-03-22 |